US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
アメリカ
USOTC
Japan Display Inc (PK) (JPDYY) 銘柄情報

Japan Display Inc (PK) (JPDYY)

3.80

0.00

(0.00%)

終了 6月13日 5:00AM

Japan Display Inc (PK) (JPDYY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

3.80

( - )

買値

2.71

売値

3.68

出来高

-

0.00 日の範囲 0.00

1.18 52 週間の範囲 7.07

時価総額

前日終値

3.80

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 121,988,312

発行済株式数

6,188,717,595

配当利回り

PER

-17.49

1 株当たり利益 (EPS)

-3.2

歳入

132.33B

純利益

-19.81B

Japan Display Inc. develops, designs, manufactures, and sells displays and related products in Japan and internationally. It also involved in planning, research, development, design, manufacture, sales, maintenance, rental, leasing, and providing related solution services of electrical equipment, el... Japan Display Inc. develops, designs, manufactures, and sells displays and related products in Japan and internationally. It also involved in planning, research, development, design, manufacture, sales, maintenance, rental, leasing, and providing related solution services of electrical equipment, electronic devices, and software; and provision of solutions and services related to medical devices. In addition, the company offers information collection and analysis services, as well as biometric information measurement using electronic technology. Its displays are used in medical, industries, and digital cameras. Japan Display Inc. was incorporated in 2002 and is headquartered in Shinagawa, Japan. 詳細を表示

セクター

Technology

業界

Hardware & Equipment

ウェブサイト

www.j-display.com

本社

Shinagawa, Japan

設立

2026

Japan Display Inc (PK) is listed in the Technology sector of the その他OTC with ticker JPDYY. The last closing price for Japan Display (PK) was US$3.80. Over the last year, Japan Display (PK) shares have traded in a share price range of US$ 1.18 to US$ 7.07.

Japan Display (PK) currently has 6,188,717,595 shares in issue. The market capitalisation of Japan Display (PK) is US$23.52 billion. Japan Display (PK) has a price to earnings ratio (PE ratio) of -17.49.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	3.8	3.8	3.8	100	3.8	DR
4	-0.03165	-0.826014902196	3.83165	3.83165	3.4	330	3.49537879	DR
12	-2.71	-41.6282642089	6.51	6.51	3.4	250	4.16016667	DR
26	2.32	156.756756757	1.48	7.07	1.2175	534	5.98594398	DR
52	2.62	222.033898305	1.18	7.07	1.18	330	5.85390311	DR
156	1.15	43.3962264151	2.65	7.07	1.03	416	3.79029175	DR
260	0.1276	3.47456704063	3.6724	7.07	1.03	1412	4.14590446	DR

JPDYY - Frequently Asked Questions (FAQ)

What is the current Japan Display Inc (PK) share price?

The current share price of Japan Display Inc (PK) is US$ 3.80

How many Japan Display Inc (PK) shares are in issue?

Japan Display Inc (PK) has 6,188,717,595 shares in issue

What is the market cap of Japan Display Inc (PK)?

The market capitalisation of Japan Display Inc (PK) is USD 23.52B

What is the 1 year trading range for Japan Display Inc (PK) share price?

Japan Display Inc (PK) has traded in the range of US$ 1.18 to US$ 7.07 during the past year

What is the PE ratio of Japan Display Inc (PK)?

The price to earnings ratio of Japan Display Inc (PK) is -17.49

What is the cash to sales ratio of Japan Display Inc (PK)?

The cash to sales ratio of Japan Display Inc (PK) is 2.62

What is the registered address of Japan Display Inc (PK)?

The registered address for Japan Display Inc (PK) is Sphere Tower Tennozu, Shinagawa, Tokyo, 140-0002

What is the Japan Display Inc (PK) website address?

The website address for Japan Display Inc (PK) is www.j-display.com

Which industry sector does Japan Display Inc (PK) operate in?

Japan Display Inc (PK) operates in the Hardware & Equipment sector

Whalatane

Whalatane 5分前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 6分前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 8分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 12分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 15分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 22分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 23分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 23分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 24分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 25分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 27分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 27分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 31分前

Just give me $1.50

Just give me $1.50 31分前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 36分前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

mrwrn2010

mrwrn2010 38分前

What I’m reading seems to indicate that Elite is still not prevented from obtaining *tentative approval* from the FDA on the OxyContin ANDA, only that they can’t get final approval until/after 8/24/27. I believe Nasrat also confirmed this last call. Ideally, we see a tentative Oxy approval sometime

Just give me $1.50

Just give me $1.50 41分前

***** I just paid for the new documents *****

Friday, June 12, 2026

STIPULATION AND ORDER REGARDING IRREVOCABLE COVENANT NOT TO COME TO MARKET AND DISMISSAL. Signed by Judge Karen M. Williams on 6/12/2026.

3331

The premise is clear: the most lucrative investments are the ones made before the rest of the world catches on. IT'S NO SECRET, THE KEY IS TO GET IN EARLY!

The SpaceX IPO created 4,400 millionaires in minutes, and over 400 people made over $100 Million, despite never turning a pr

WATERFALL1

WATERFALL1 44分前

Agreed

We are facing reversal to North direction

Patience is needed

WATERFALL1

WATERFALL1 45分前

Do you want to kidding us with your opinion ?

grantastic

grantastic 47分前

I'm not here to "help" scammers that make bogus claims.

In hindsight, most of my APRU takes were proven accurate. Were they "helpful" to anyone? I can hope so, but I have no idea if I actually saved anyone from the idiotic mistake of thinking APRU was a legitimate enterprise.

Japan Display (PK)

Barclays Bank Plc Issuer...

Societe Generale SCF SA ...

Exchange Traded

6.21% Gtd Srs 6 Nts 25/0...

Vontobel Financial Produ...

Invesco RAFI Emerging Ma...

Euronext Eurozone 300 NR

Connecticut Light and Po... (ID)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。